Filing Flows › Steris (STE) › How it makes money
How Steris (STE) makes money
Steris (STE) made $1.6B of revenue in the second quarter fiscal 2027 (Q2 FY27), +9% from a year earlier. Healthcare brought in $1.1B (71%); AST brought in $296M (19%); Life Sciences: brought in $171M (11%). Of every dollar of revenue, 45¢ was left as gross profit, 19¢ was left as operating profit, 13¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q2 FY27
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Healthcare | $1.1B | 70.7% | +7% | +9% |
| AST | $296M | 18.6% | -0.7% | +5% |
| Life Sciences: | $171M | 10.7% | +16% | +18% |
Where each dollar of revenue goes
| Line | Q2 FY27 | % of revenue |
|---|---|---|
| Revenue | $1.6B | 100.0% |
| Cost of revenue | $878M | 55.3% |
| Gross profit | $711M | 44.7% |
| Operating expenses | $416M | 26.2% |
| Operating profit | $294M | 18.5% |
| Income tax | $73.9M | 4.7% |
| Net earnings | $214M | 13.5% |
| Operating cash flow | $289M | 18.2% |
| Free cash flow | $213M | 13.4% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 FY27 | $1.6B | +9% |
| Q1 FY27 | $1.5B | +7% |
| Q4 FY26 | $1.6B | +7% |
| Q3 FY26 | $1.5B | +9% |
| Q2 FY26 | $1.5B | +10% |
| Q1 FY26 | $1.4B | +9% |
| Q4 FY25 | $1.5B | +4% |
From Steris' 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Steris make money?
Steris (STE) made $1.6B of revenue in the second quarter fiscal 2027 (Q2 FY27), +9% from a year earlier. Healthcare brought in $1.1B (71%); AST brought in $296M (19%); Life Sciences: brought in $171M (11%). Of every dollar of revenue, 45¢ was left as gross profit, 19¢ was left as operating profit, 13¢ was left as net earnings.
What is Steris' biggest business?
Healthcare: $1.1B in the second quarter fiscal 2027, 71% of revenue, +9% from a year earlier.
What is Steris' profit margin?
Net earnings were $214M, 13.5% of revenue, in the second quarter fiscal 2027; the operating margin was 18.5%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.